Court Upholds Medicare Part B Reimbursement Cuts for 340B Drugs
The Court of Appeals for District of Columbia Circuit issued a 2-1 decision today upholding Medicare Part B reimbursement cuts for 340B drugs from ASP+6% to ASP-22.5%. The case is…
President Trump Signs Executive Orders on Lowering Drug Prices – Potential Impact for 340B Safety-Net Providers
On Friday, July 24, President Donald Trump signed four Executive Orders designed to lower the cost of prescription drugs. This alert will focus on three Orders that could impact 340B…
Sanofi Announces 340BESP Participation and Consequences
Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate in a new web-based platform, 340B…
Press Release: White House Executive Orders Undermine 340B Program
Washington, D.C. – Shannon Stephenson, president of RWC-340B, said, “The White House Executive Orders related to 340B set a very dangerous precedent at the worst time, when safety net providers…
Recent Actions by Drug Manufacturers Merck and Eli Lilly Pose a Threat to Safety-Net Provider’s Ability to Access Drugs at 340B Prices
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they…